Research of Biomarkers of Activity and Efficacy of BIBW2992 in Untreated Non-metastatic HNSCC Patients

NCT01415674 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

61

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma, Squamous Cell of Head and Neck

Interventions

DRUG: Afatinib

Sponsor

UNICANCER